Aytu BioPharma Statistics Share Statistics Aytu BioPharma has 6.28M
shares outstanding. The number of shares has increased by 2.12%
in one year.
Shares Outstanding 6.28M Shares Change (YoY) 2.12% Shares Change (QoQ) 1.77% Owned by Institutions (%) 55.68% Shares Floating 6.63M Failed to Deliver (FTD) Shares 409 FTD / Avg. Volume 0.22%
Short Selling Information The latest short interest is 461.81K, so 5.14% of the outstanding
shares have been sold short.
Short Interest 461.81K Short % of Shares Out 5.14% Short % of Float 6.51% Short Ratio (days to cover) 5.89
Valuation Ratios The PE ratio is -1.01 and the forward
PE ratio is -1.67.
Aytu BioPharma's PEG ratio is
0.04.
PE Ratio -1.01 Forward PE -1.67 PS Ratio 0.21 Forward PS 0.2 PB Ratio 0.72 P/FCF Ratio -6.32 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Aytu BioPharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.26,
with a Debt / Equity ratio of 0.1.
Current Ratio 1.26 Quick Ratio 1.07 Debt / Equity 0.1 Debt / EBITDA -0.24 Debt / FCF -0.86 Interest Coverage -2.11
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $650.8K Profits Per Employee $-132.96K Employee Count 102 Asset Turnover 0.53 Inventory Turnover 1.8
Taxes Income Tax 437K Effective Tax Rate -3.18%
Stock Price Statistics The stock price has increased by -19.15% in the
last 52 weeks. The beta is 0.28, so Aytu BioPharma's
price volatility has been higher than the market average.
Beta 0.28 52-Week Price Change -19.15% 50-Day Moving Average 2.27 200-Day Moving Average 1.77 Relative Strength Index (RSI) 38.75 Average Volume (20 Days) 187,307
Income Statement In the last 12 months, Aytu BioPharma had revenue of 66.38M
and earned -13.56M
in profits. Earnings per share was -2.16.
Revenue 66.38M Gross Profit 45.83M Operating Income -7.83M Net Income -13.56M EBITDA -7.83M EBIT -10.04M Earnings Per Share (EPS) -2.16
Full Income Statement Balance Sheet The company has 30.95M in cash and 1.86M in
debt, giving a net cash position of 29.09M.
Cash & Cash Equivalents 30.95M Total Debt 1.86M Net Cash 29.09M Retained Earnings -333.54M Total Assets 124.43M Working Capital 16.11M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -1.94M
and capital expenditures -228K, giving a free cash flow of -2.17M.
Operating Cash Flow -1.94M Capital Expenditures -228K Free Cash Flow -2.17M FCF Per Share -0.34
Full Cash Flow Statement Margins Gross margin is 69.04%, with operating and profit margins of -11.79% and -20.43%.
Gross Margin 69.04% Operating Margin -11.79% Pretax Margin -20.71% Profit Margin -20.43% EBITDA Margin -11.79% EBIT Margin -11.79% FCF Margin -3.26%
Dividends & Yields AYTU does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for AYTU is $8,
which is 321.1% higher than the current price. The consensus rating is "Buy".
Price Target $8 Price Target Difference 321.1% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 6, 2023. It was a
backward
split with a ratio of 1:20.
Last Split Date Jan 6, 2023 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -3.01 Piotroski F-Score 3
